1187 The predictive value of core AG testing in the management of patients receiving PEG-IFN/ribavirin treatment — relevance for the early identification of non-responders and relapsers

Authors :: Pascale Berthillon
Pierre Pradat
Nicolas Voirin
Gaston Picchio
Johannes Wiegand
Juan Ignacio Esteban
Marianne Maynard
Hans L. Tillmann
M.P. Manns
Maria Buti
Source :: Hepatology. 38:729-729
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Oncology
medicine.medical_specialty
Non responders
chemistry.chemical_compound
Hepatology
chemistry
business.industry
Internal medicine
Ribavirin
medicine
Physical therapy
business
Predictive value

Tools